Latest updates for Theia Trial

Fresh curated links around THEIA Trial are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • GEMINI launches ai-assisted trial with partners to prevent delirium across 13 hospitals
  • TTC Safety in HER2+ Metastatic Breast Cancer: Key Findings
  • Clinical Conundrum — What is the Role of Thrombolysis in Central Retinal Artery Occlusion?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hospitalnews.com /1 month ago

GEMINI launches ai-assisted trial with partners to prevent delirium across 13 hospitals

HN Summary • A major Canadian AI trial is launching across 13 Ontario hospitals, involving approximately 15,000 patients.  • The AI tool predicts which patients are at highest risk...

Read source
letlifehappen.com /1 month ago

TTC Safety in HER2+ Metastatic Breast Cancer: Key Findings

By: Jessica Nye, Ph From: oncologynurseadvisor.com n a safety review of the HER2CLIMB trial, grade 3 or higher AEs occurred in 55.2% of patients receiving TTC compared with 48.7% r...

Read source
rebelem.com /5 days ago

Clinical Conundrum — What is the Role of Thrombolysis in Central Retinal Artery Occlusion?

While CRAO is often called an "eye stroke," current evidence does not support routine thrombolysis. Recent randomized trials, such as THEIA and TenCRAOS, show no visual benefit ove...

Read source
seekingalpha.com /1 month ago

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial

Read source
emcrit.org /4 days ago

A Study in Priors Part 3

In 2010, the CRASH-2 trial was published in the Lancet.[1] The authors randomized 20,211 trauma patients with, or at risk of, significant hemorrhage within 8 hours of injury to eit...

Read source
prweb.com /1 month ago

Chemo-Resistant Pancreatic Tumor Liquefies and Drains Several Months after Receiving Proprietary Intratumoral EpCAM/CD3...

Peer-reviewed case report documents 90% volume reduction together with extensive necrosis — achieved without surgery or full-dose chemotherapy after gemcitabine failed SAN DIEGO, S...

Read source
seekingalpha.com /1 month ago

Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial - Slideshow

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Theia Trial

rebelem.com

Recent coverage from public sources
Public source

emcrit.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

hospitalnews.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source